Peyman JA et al. |
HLA-DR genes are silenced in human trophoblasts and stimulation of signal transduction pathways does not circumvent interferon-gamma unresponsiveness. |
1992 |
Transplant. Proc. |
pmid:1533073
|
Kecskemeti V and Balogh I |
Cardiac electrophysiologic and ultrastructural effects of platelet-activating factor and its antagonist BN 52021. |
1995 |
Transplant. Proc. |
pmid:7482928
|
Yin M et al. |
Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7482939
|
Spiegel HU et al. |
Beneficial effect of the platelet-activating factor antagonist WEB 2170 on reperfusion injury after orthotopic liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7482955
|
Borobia FG et al. |
Platelet-activating factor antagonist BN52021 improves survival in normothermic liver ischemia in rats. |
1993 |
Transplant. Proc. |
pmid:8356661
|
Iwamoto H et al. |
Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. |
2000 |
Transplant. Proc. |
pmid:11119873
|
Da Costa M et al. |
Prolongation of rat heart allograft survival using low-dose cyclosporine and PAF antagonist WEB 2170. |
1990 |
Transplant. Proc. |
pmid:2389490
|
Bergmann R et al. |
Effects of a PAF-antagonist (WEB 2086) on hyperacute xenogeneic rejection in ex vivo perfused kidneys. |
1990 |
Transplant. Proc. |
pmid:2389511
|
|
Immunomodulation: other approaches. |
1988 |
Transplant. Proc. |
pmid:3347955
|
Renkonen R et al. |
Second messenger pathways in lymphocyte binding and penetration through graft vascular endothelium. |
1991 |
Transplant. Proc. |
pmid:1846709
|
Pignol B et al. |
Potentiation of immunosuppressive action of cyclosporine A by platelet-activating factor antagonists: an approach of the mechanism of action of these drugs in the prevention of graft rejection. |
1988 |
Transplant. Proc. |
pmid:3259039
|
Takada Y et al. |
Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation. |
1995 |
Transplant. Proc. |
pmid:7879169
|
Yin M et al. |
Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury. |
1995 |
Transplant. Proc. |
pmid:7879180
|
Hirt SW et al. |
Antagonisation of platelet activating factor--a new therapeutic concept for improvement of organ quality in lung preservation. |
1992 |
Transpl. Int. |
pmid:14621825
|
Torras J et al. |
Protective effect of the PAF antagonist BN 52021 in an experimental renal warm ischemia model. |
1993 |
Transpl. Int. |
pmid:8347271
|
Räisänen A et al. |
Effect of platelet-activating factor (PAF) receptor blockers on smooth muscle cell replication in vitro and allograft arteriosclerosis in vivo. |
1993 |
Transpl. Int. |
pmid:8216700
|
Shukla SD et al. |
Response to platelet-activating factor in human platelets stored and aged in plasma. Decrease in aggregation, phosphoinositide turnover, and receptor affinity. |
1989 Jul-Aug |
Transfusion |
pmid:2546298
|
Guerrant RL et al. |
Diarrhea, demography and cell signaling: lessons from microbial toxins. |
1997 |
Trans. Am. Clin. Climatol. Assoc. |
pmid:9108674
|
Melo RC et al. |
Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. |
2005 |
Traffic |
pmid:16138901
|
Tai H et al. |
TMVA, a snake C-type lectin-like protein from Trimeresurus mucrosquamatus venom, activates platelet via GPIb. |
2004 |
Toxicon |
pmid:15501291
|